Qube Research & Technologies LTD Immunity Bio, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.35 - $4.78 $34,865 - $123,448	-25,826 Reduced 51.02%	24,796 $45,000
Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.77 $220,205 - $342,710	50,622 New	50,622 $256,000
Q2 2022 Aug 15, 2022	BUY	$2.68 - $6.14 $224,825 - $515,084	83,890 Added 162.06%	135,655 $505,000
Q1 2022 May 09, 2022	SELL	$5.05 - $7.53 $200,732 - $299,309	-39,749 Reduced 43.43%	51,765 $290,000
Q4 2021 Feb 01, 2022	BUY	$5.67 - $10.18 $518,884 - $931,612	91,514 New	91,514 $556,000
Q2 2021 Aug 13, 2021	SELL	$13.41 - $22.4 $421,664 - $704,345	-31,444 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$12.83 - $42.25 $403,426 - $1.33 Million	31,444 New	31,444 $746,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.